ad image
CDMO Market Insight, Pricing and Benchmarking Reports
NICE INSIGHT REPORT

Antibody–Drug Conjugate, ADC:Market Insight, CDMO Pricing and Competitor Benchmarking

Updated Monthly
  • 2025 CDMO pricing data for competitive benchmarking

  • Proprietary analysis of ADC-based clinical trials

  • ADC manufacturing process and areas of innovation

  • 30+ company profiles for a comprehensive CDMO landscape

  • Exclusive insights into the ADC market and breakthroughs

  • Projections on one of the most anticipated markets

Key market insights for innovators, CDMOs and investors in the Antibody–Drug Conjugate industry.

The market trends that decision makers need to know

The market trends that decision makers need to know

Our complete Market Analysis uses scientific insights from PhDs and researchers to provide an exhaustive overview of the ADC industry. From the emergence of ADCs as cancer treatments to how big pharma has penetrated ADC, stay ahead of market trends with our report.

Exclusive pricing data to benchmark against peers

Exclusive pricing data to benchmark against peers

Keep your sales team ahead of the curve by using our primary data for an accurate pricing comparison. Our Market Analysis provides a manufacturing process and strategic pricing study designed to give CDMOs a competitive edge.

Market intelligence for research, manufacturing and pricing all in one report.

The Antibody–Drug Conjugate, ADC: Market Insight, CDMO Pricing and Competitor Benchmarking provides

/images/nice-insight/report/landing-page/2025/01/09/current-pricing-data-1736422757805.webp

Current pricing data for benchmarking in the emerging market

/images/nice-insight/report/landing-page/2025/01/09/manufacturing-technologies-1736422765103.webp

Manufacturing technologies that are invaluable for ADC manufacturers

/images/nice-insight/report/landing-page/2025/01/09/hundreds-of-pages-1736422787705.webp

Exclusive insights of market intelligence for your sales team

/images/nice-insight/report/landing-page/2025/01/09/30plus-company-profiles-1736422792012.webp

30+ company profiles of top CDMOs in the U.S., Europe and Asia

/images/nice-insight/report/landing-page/2025/01/09/pipeline-overview-1736422812128.webp

Pipeline overview and the approval and regulatory landscape

/images/nice-insight/report/landing-page/2025/01/09/value-chain-analysis-1736422828300.webp

Value-chain analysis and the unique complexities in ADC production

Over 700 hours of data collection and analysis —
interviews with CDMO owners, KOLs and industry experts